Biblio
Export 1157 results:
Author Title Type [ Year] Filters: First Letter Of Last Name is R [Clear All Filters]
“African Ancestry Individuals with Higher Educational Attainment Are Resilient to Alzheimer's Disease Measured by pTau181.”, J Alzheimers Dis, vol. 98, no. 1, pp. 221-229, 2024.
, “Alterations in Synaptic Connectivity and Synaptic Transmission in Alzheimer's Disease with High Physical Activity.”, J Alzheimers Dis, 2024.
, “Blood-Based mtDNA Quantification Indicates Population-Specific Differences Associated with Alzheimer's Disease-Related Risk.”, J Alzheimers Dis, vol. 97, no. 3, pp. 1407-1419, 2024.
, “FACEmemory®, an Innovative Online Platform for Episodic Memory Pre-Screening: Findings from the First 3,000 Participants.”, J Alzheimers Dis, vol. 97, no. 3, pp. 1173-1187, 2024.
, “FACEmemory®, an Innovative Online Platform for Episodic Memory Pre-Screening: Findings from the First 3,000 Participants.”, J Alzheimers Dis, vol. 97, no. 3, pp. 1173-1187, 2024.
, “FACEmemory®, an Innovative Online Platform for Episodic Memory Pre-Screening: Findings from the First 3,000 Participants.”, J Alzheimers Dis, vol. 97, no. 3, pp. 1173-1187, 2024.
, “FACEmemory®, an Innovative Online Platform for Episodic Memory Pre-Screening: Findings from the First 3,000 Participants.”, J Alzheimers Dis, vol. 97, no. 3, pp. 1173-1187, 2024.
, “Frontal Cortex Lipid Alterations During the Onset of Alzheimer's Disease.”, J Alzheimers Dis, vol. 98, no. 4, pp. 1515-1532, 2024.
, “Improving Healthcare Quality and Clinical Outcomes for Persons with Dementia in the Sub-Acute Hospital Through Person-Centered Care Practice.”, J Alzheimers Dis, vol. 98, no. 2, pp. 619-628, 2024.
, “Mendelian Randomization of Blood Metabolites Suggests Circulating Glutamine Protects Against Late-Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 98, no. 3, pp. 1069-1078, 2024.
, “Mendelian Randomization of Blood Metabolites Suggests Circulating Glutamine Protects Against Late-Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 98, no. 3, pp. 1069-1078, 2024.
, “Mendelian Randomization of Blood Metabolites Suggests Circulating Glutamine Protects Against Late-Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 98, no. 3, pp. 1069-1078, 2024.
, “Accumulation of pTau231 at the Postsynaptic Density in Early Alzheimer's Disease.”, J Alzheimers Dis, vol. 92, no. 1, pp. 241-260, 2023.
, “The Anti-Amyloid Monoclonal Antibody Lecanemab: 16 Cautionary Notes.”, J Alzheimers Dis, vol. 94, no. 2, pp. 497-507, 2023.
, “Association of Sarcopenia and Its Defining Components with the Degree of Cognitive Impairment in a Memory Clinic Population.”, J Alzheimers Dis, vol. 96, no. 2, pp. 777-788, 2023.
, “Associations Between Local Area Deprivation and Physical Activity Participation in People with Cognitive Impairment in the North East of England.”, J Alzheimers Dis, vol. 95, no. 1, pp. 265-273, 2023.
, “Associations Between Local Area Deprivation and Physical Activity Participation in People with Cognitive Impairment in the North East of England.”, J Alzheimers Dis, vol. 95, no. 1, pp. 265-273, 2023.
, “Associations of the Harvard Automated Phone Task and Alzheimer's Disease Pathology in Cognitively Normal Older Adults: Preliminary Findings.”, J Alzheimers Dis, vol. 94, no. 1, pp. 217-226, 2023.
, “Cardiorespiratory Fitness Attenuates the Deleterious Effects of Sleep Apnea on Cerebral Structure and Perfusion in the Wisconsin Sleep Cohort Study.”, J Alzheimers Dis, vol. 95, no. 2, pp. 427-435, 2023.
, “Cerebral Gray and White Matter Monogalactosyl Diglyceride Levels Rise with the Progression of Alzheimer's Disease.”, J Alzheimers Dis, vol. 95, no. 4, pp. 1623-1634, 2023.
, “Cleveland Clinic Cognitive Battery (C3B): Normative, Reliability, and Validation Studies of a Self-Administered Computerized Tool for Screening Cognitive Dysfunction in Primary Care.”, J Alzheimers Dis, vol. 92, no. 3, pp. 1051-1066, 2023.
, “Coexistence of Amyotrophic Lateral Sclerosis and Alzheimer's Disease: Case Report and Review of the Literature.”, J Alzheimers Dis, vol. 95, no. 4, pp. 1383-1399, 2023.
, “Cognitive and Neuropsychological Profiles in Alzheimer's Disease and Primary Age-Related Tauopathy and the Influence of Comorbid Neuropathologies.”, J Alzheimers Dis, vol. 92, no. 3, pp. 1037-1049, 2023.
, “COVID-19 as a Risk Factor for Alzheimer's Disease.”, J Alzheimers Dis, vol. 91, no. 1, pp. 1-23, 2023.
, “Deep Reinforcement Learning-Based Retinal Imaging in Alzheimer's Disease: Potential and Perspectives.”, J Alzheimers Dis, vol. 94, no. 1, pp. 39-50, 2023.
,